Physician
Oncology
Dr. Ranee Mehra, MD
|
|
Give Review
Ranee Mehra is an expert in the field of Oncology. She studied medicine at NYU School of Medicine. She received awards:"CMS Meaningful Use Stage 1 Certification". Ranee Mehra has written publications. She has 23 publications published with PubMed. The lastest paper is: 'Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.' Ranee Mehra is registered with Medicare.
Publications
- Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung Cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.
- Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal Cancer.
- HPV-negative head and neck squamous cell Carcinomas: how can we use the tumor protein signature?
- A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma.
- p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell Carcinomas of unknown primary.
- Increasing time to treatment initiation for head and neck Cancer: An analysis of the National Cancer Database.
- Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative On...
- Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung Cancer.
- Prognostic significance of human papillomavirus in recurrent or metastatic head and neck Cancer: an analysis of Eastern Cooperative Oncology Group trials.
- Ceritinib in ALK-rearranged non-small-cell lung Cancer.
- HPV-associated lung Cancers: an international pooled analysis.
- Multidisciplinary Therapy of Stage IIIA Non-Small-Cell Lung Cancer: Long-term Outcome of Chemoradiation With or Without Surgery.
- Baseline health perceptions, dysphagia, and survival in patients with head and neck Cancer.
- Quantification of excision repair cross complementing group 1 (ERCC1) and survival in p16-negative squamous cell head and neck Cancers.
- Aurora kinases in head and neck Cancer.
- Dysplasia at the margin? Investigating the case for subsequent therapy in 'Low-Risk' squamous cell Carcinoma of the oral tongue.
- Extranodal extension of Metastatic Papillary Thyroid Carcinoma: Correlation with biochemical endpoints, nodal persistence and Systemic disease progression.
- False-Positive Scalp Activity in 131I Imaging Associated with Hair Coloring.
- Unilateral neck therapy in the human papillomavirus ERA: Accepted regional spread patterns.
- Targeting C4-Demethylating Genes in the Cholesterol Pathway Sensitizes Cancer Cells to EGF Receptor Inhibitors via Increased EGF Receptor Degradation.
- Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling".
- Management of human papillomavirus-positive and human papillomavirus-negative head and neck Cancer.
Schools
New York University School Of Medicine
Yale University School Of Med
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Yale-New Haven Hospital -
NYU School of Medicine
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital
Drug Facts
| NPI NUMBER | 1760411326 | |
| NPPES Provider LastName | MEHRA | |
| NPPES Provider FirstName | RANEE | |
| NPPES Provider ZIPCode | 19111 | |
| NPPES Provider State | PA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 269.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 6.32 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760411326 |
| Last Name Of The Provider | MEHRA |
| First Name Of The Provider | RANEE |
| View All |
Similar Doctors
|
Dr. Frederick S. Brunk, MD |
|
|
Dr. Joseph A. Treat, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gataree Ngarmchamnanrith, MD |
|
|
Dr. Holly Dushkin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Avnish Bhatia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen M. Hahn, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Marlise R. Luskin, MD
This Doctor is OpenDoctor Recommended.
|